9 patents currently held

1 more in force is now held by another company

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Oct 2033. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Oct 2033

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033 203420352036203720382039204020412042204320442045

notable patents all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Visualization and Quantification of Lung Disease Utilizing Image Registration US 9,760,989

The most cited patent in this portfolio, cited by 34 later US patents, top 10% of utility patents granted in 2017 in our data. Protection runs to 2034.

Ends Aug 2034 · High confidence Also notable

Treatment Outcome Prediction for Lung Volume Reduction Procedures US 9,504,529

Cited by 31 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.

Ends Apr 2034 · High confidence Also notable

Visualization and Characterization of Pulmonary Lobar Fissures US 9,014,445

Cited by 32 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.

Ends Oct 2033 · High confidence

Formerly held, still cited

Notable

Treatment Outcome Prediction for Lung Volume Reduction Procedures US 10,226,299

The most cited patent in this portfolio, cited by 37 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.

now held by Vida Daignostics, Inc.

Ends Feb 2034 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 16, 2027
The maintenance fee for Subject Specific Coordinatization and Virtual Navigation Systems and Methods (US 11,875,459) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 4 largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Visualization and Quantification of Lung Disease Utilizing Image Registration	2 in force	to Aug 2034
Systems and Methods for Quantifying Regional Fissure Features	1 in force	to Aug 2036
Treatment Outcome Prediction for Lung Volume Reduction Procedures	1 in force	to Apr 2034
Visualization and Characterization of Pulmonary Lobar Fissures	1 in force	to Oct 2033

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 9,014,445	Visualization and Characterization of Pulmonary Lobar Fissures In force Term ends Oct 17, 2033 · High confidence	In force	Term ends Oct 17, 2033	High confidence
US 9,504,529	Treatment Outcome Prediction for Lung Volume Reduction Procedures In force Term ends Apr 12, 2034 · High confidence	In force	Term ends Apr 12, 2034	High confidence
US 10,255,679	Visualization and Quantification of Lung Disease Utilizing Image Registration In force Term ends May 15, 2034 · High confidence	In force	Term ends May 15, 2034	High confidence
US 9,760,989	Visualization and Quantification of Lung Disease Utilizing Image Registration In force Term ends Aug 3, 2034 · High confidence	In force	Term ends Aug 3, 2034	High confidence
US 10,165,964	Systems and Methods for Quantifying Regional Fissure Features In force Term ends Aug 11, 2036 · High confidence	In force	Term ends Aug 11, 2036	High confidence
US 11,176,666	Cut-Surface Display of Tubular Structures In force Term ends Jan 17, 2040 · High confidence	In force	Term ends Jan 17, 2040	High confidence
US 11,875,459	Subject Specific Coordinatization and Virtual Navigation Systems and Methods In force Term ends Feb 3, 2042 · High confidence	In force	Term ends Feb 3, 2042	High confidence
US 12,266,111	Visualization of Sub-Pleural Regions In force Term ends Oct 27, 2042 · High confidence	In force	Term ends Oct 27, 2042	High confidence
US 12,086,980	Pulmonary Analysis Using Transpulmonary Pressure In force Term ends Dec 9, 2042 · High confidence	In force	Term ends Dec 9, 2042	High confidence

Also on record, not counted in the 9: 1 patent in force now held by others · 4 patents ended · 1 application pending · 5 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Vida Diagnostics, Inc.